The Antibody Society

the official website of the antibody society

The Adaptive Immune Receptor Repertoire Community of The Antibody Society

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Directors and Officers
    • The Antibody Society’s Committees
      • AIRR Community Committee
      • Communication & Membership Committee
      • Meetings Committee
    • Sponsors & Partners
  • Society meetings
    • Harnessing Cytokines for Cancer Immunotherapy Symposium
    • Biopharmaceutical Informatics Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2023
      • 2022 Antibody Engineering & Therapeutics
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 2023
    • FOCIS Symposia
  • AIRR Community
    • AIRR News
    • AIRR Publications
    • AIRR Meetings
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-committees
      • Communications Sub-committee
      • Executive Sub-committee
      • Inferred Allele Review Committee
      • Meetings Sub-committee
    • AIRR Data Commons
    • AIRR Community Calendar
    • AIRR Community Webinar Series
    • On AIRR – An AIRR Community Podcast
    • AIRR Community Resources
    • AIRR Community Service Prize 2022
  • Members only
    • Login
    • Note to members
    • James S. Huston Antibody Science Talent Award
      • 2021 James S. Huston Antibody Science Talent Award Recipient
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • JSH Award Criteria
    • Science Writing Competition
      • Science Writing Competition Winners
    • Imaging Competition
    • Research Competitions
      • Research Competition Winners
    • Member discount codes
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics
    • Adaptive Immune Receptor Repertoires
    • Antibody Discovery & Development
    • Commercializing Antibody Therapeutics
    • Antibodies to Watch
    • Antibody Validation
  • COVID-19
    • Guide to “Coronavirus in the Crosshairs”
    • COVID-19 Biologics Tracker
    • Meeting Report: The Diagnostic Landscape for COVID-19
You are here: Home / The AIRR Community / AIRR Community Meetings / AIRR Community Special Event: “Response to COVID-19”

AIRR Community Special Event: “Response to COVID-19”

Due to the unprecedented nature of the COVID-19 pandemic and the need for rapid scientific progress, the Adaptive Immune Receptor Repertoire (AIRR) Community of The Antibody Society held a special event focused on AIRR-sequencing data and COVID-19. The virtual meeting provided recent analyses of the B- and T-cell receptor repertoires of COVID-19 patients. In addition, explored a key objective of the AIRR Community in the context of the pandemic: How the scientific response to the COVID-19 pandemic might be leveraged to promote the implementation of standards for AIRR-seq data.

For complete details download the full program.

Leveraging AIRR-sequencing Data
to Inform the Biology of COVID-19

A 3-day virtual meeting was held:
Tuesday – Thursday, 8-10 Sept. at 8-11AM PDT / 11AM-2 PM EDT / 5-8PM CEST

Event Recordings:  Available on our YouTube Channel

Event Synopsis:

Day 1: How T-cell receptor repertoire data inform the pathophysiology of COVID-19, implications for diagnostics, therapeutics, and/or vaccines – 4 presentations followed by a panel discussion.

Session Moderator & Speakers:

  • Lindsay Cowell, UT Southwestern Medical Center, USA (Moderator)
  • Aleksandra M. Walczak, Centre National Recherche Scientifique (CNRS), France
  • Donjete Simnica, Martin-Luther University, Germany
  • Pandurangan Vijayanand, La Jolla Institute for Immunology, USA
  • Jonathan Carlson, Microsoft Research, USA

Day 2: How B-cell receptor repertoire data inform the pathophysiology of COVID-19, implications for diagnostics, therapeutics, and/or vaccines – 4 presentations followed by a panel discussion.

Session Moderator & Speakers:

  • Nina Luning Prak, University of Pennsylvania, USA (Moderator & Speaker)
  • Charlotte Deane, University of Oxford, UK
  • Kenneth Hoehn, Yale University, USA
  • Bryan Briney, Scripps Research, USA

Day 3: COVID-19: A catalyst for the implementation of the FAIR guiding principles* for AIRR-seq data
*See the FAIR guiding principles for scientific data management and stewardship.

Panel 1 Topic: State of FAIR 2020: Achievements, Catalysts, Obstacles and Risks

Panel Moderator & Members:

  • Christian Busse, German Cancer Research Center (Moderator)
  • Christine Choirat, Swiss Data Science Center
  • Rob Hooft, Dutch Techcenter for Life Sciences, Netherlands
  • Eva Maria Moar, EURAC Research, Italy

Panel 2 Topic: How are database providers making COVID-19 data FAIR?

Panel Moderator & Members:

  • Bjoern Peters, La Jolla Institute for Immunology, USA (Moderator)
  • Felix Breden, Simon Fraser University, Canada
  • Patrick Dunn, Northrop Grummon Health Solutions, USA
  • Erica Ollmann Saphire, La Jolla Institute for Immunology, USA
  • Darren Natale, Georgetown University Medical Center, USA

Panel 3 Topic: Implementing policies to support FAIR data

Panel Moderator & Members:

  • Jamie Scott, Simon Fraser University, Canada (Moderator)
  • Sarah Callaghan, Cell Press, UK
  • Luis Eduardo Coelho Andrade, Universidade Federal de São Paulo, Brazil
  • Joe Breen, DAIT/NIAID, National Institutes of Health, USA
  • Jake Glanville, Distributed Bio & Centivax, USA

Organized by the AIRR-C Meetings Sub-committee: Davide Bagnara, Pam Borghardt (Meeting Manager), Jean-Philippe Bürckert, Ramit Mehr and Jamie Scott.

Thank you to the AIRR-C Communication Sub-committee for their assistance with this event!

For information about future events contact: meetings@AIRRC.antibodysociety.org.

 

Past AIRR meetings

You can find information, videos and agendas of the past meetings here: Information on past AIRR meetings

AIRR Community News

AIRR Data Commons and iReceptor Science Gateway Start Major Collaboration with Type-1 Diabetes Researchers

January 11, 2023 By Pam Borghardt

The AIRR Community is pleased to announce the addition of a new Type 1 Diabetes (T1D) focused repository in the AIRR Data Commons. This is a collaboration between the iReceptor team (Simon Fraser University), The Sugar Science group, the Aaron Michels Lab (University of Colorado), and the Todd Brusko Lab (University of Florida) among others. This repository contains the first fully HLA/MHC […]

On AIRR Podcast Episode 10 Now Available!

December 30, 2022 By Pam Borghardt

A new episode of #OnAIRR – the podcast of the AIRR Community is now available. Prof Ralf Küppers, @UniklinikEssen, Germany discusses AIRR-Seq in understanding B cell lymphomas. Building upon Ralf’s background in B cell differentiation in health and pathogenesis of human B cell lymphomas, we discuss how micro-dissection and Sanger sequencing is still the method […]

AIRR-C WG/SC Calls

All times are in ET (Americas/New York)

Click here for full calendar view

BCF23 - Registration Deadline
Mon, January 30, 2023
Call - ComRepo
10:00
Thu, February 2, 2023
Call - Diagnostics WG
11:00
Tue, February 14, 2023
Call - Exec SC
11:00
Thu, February 16, 2023
Call - Standards
14:00
Mon, February 20, 2023

mabs

mabs

The Official Journal of The Antibody Society

Recent AIRR Publications

  • Trück J et al, Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling (eLife, 2021)
  • Arnaout RA, Prak ETL, Schwab N, Rubelt F. Adaptive Immune Receptor Repertoire Community. The Future of Blood Testing Is the Immunome. (Frontiers in Immunology, 2021).

 
See all publications

Archives

Follow Us Online

  • Email
  • LinkedIn
  • Twitter
  • YouTube
  • Slack
  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals